chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash
Clinical narrative: flat rash around injection site; redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (flat rash around injection site) and VACCINATION SITE ERYTHEMA (redness around the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (flat rash around injection site) and VACCINATION SITE ERYTHEMA (redness around the injection site). At the time of the report, VACCINATION SITE RASH (flat rash around injection site) and VACCINATION SITE ERYTHEMA (redness around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medicines was not reported by reporter  Treatment information was not provided   This case was linked to MOD-2021-017996 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: follow up received on 16-jun-2021 contains no new information
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot; Injection site itching; Redness; Swelling; Sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Sore) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 075L2(or Z)0A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Sulfonamide allergy, Parkinson's disease, Diabetes, Blood pressure high and Hypercholesterolemia. Concomitant products included DULAGLUTIDE (TRULICITY), LIDOCAINE, PRILOCAINE (LIDOPIN [LIDOCAINE;PRILOCAINE]), METOPROLOL, CLONAZEPAM and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hot), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Sore). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Sore) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-197502 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Follow up received on 2/JUN/2021updated Event outcome recovered.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Rhinorrhoea
Clinical narrative: Covid 19 diagnosis; slight headache; stuffy nose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid 19 diagnosis), HEADACHE (slight headache) and RHINORRHOEA (stuffy nose) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported.).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced HEADACHE (slight headache) and RHINORRHOEA (stuffy nose). On 19-Jan-2021, the patient experienced COVID-19 (Covid 19 diagnosis). At the time of the report, COVID-19 (Covid 19 diagnosis), HEADACHE (slight headache) and RHINORRHOEA (stuffy nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment information was provided concomitant medication included vitiams; Sender's Comments: Very limited information regarding the events 'COVID-19' and 'Rhinorrhea' has been provided at this time. Further information has been requested. For the event of 'COVID-19', it is unlikely related to the vaccine.  Based on the current available information and temporal association between the use of the product and the start date of the event 'Headache', a causal relationship cannot be excluded. Further information has been requested.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypersomnia
Clinical narrative: Headache; Slept a lot; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HEADACHE (Headache) and HYPERSOMNIA (Slept a lot) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced HEADACHE (Headache) and HYPERSOMNIA (Slept a lot). On 31-Jan-2021, HYPERSOMNIA (Slept a lot) had resolved. On 01-Feb-2021, HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported  Treatment details included Tylenol and pain killer.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction, Pain in extremity, Pruritus, Rash erythematous
Clinical narrative: Arm ached; Red rash; Itching; Feels like she received the shot today; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm ached), RASH ERYTHEMATOUS (Red rash), PRURITUS (Itching) and ADVERSE DRUG REACTION (Feels like she received the shot today) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LOSARTAN and LEVOTHYROXINE for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm ached), RASH ERYTHEMATOUS (Red rash), PRURITUS (Itching) and ADVERSE DRUG REACTION (Feels like she received the shot today). At the time of the report, PAIN IN EXTREMITY (Arm ached), RASH ERYTHEMATOUS (Red rash), PRURITUS (Itching) and ADVERSE DRUG REACTION (Feels like she received the shot today) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Walking disability
Clinical narrative: having harder time walking after vaccination; started walking kind of funny after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (having harder time walking after vaccination) and WALKING DISABILITY (started walking kind of funny after vaccination) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Parkinson's disease and Walking difficulty.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced GAIT DISTURBANCE (having harder time walking after vaccination) and WALKING DISABILITY (started walking kind of funny after vaccination). At the time of the report, GAIT DISTURBANCE (having harder time walking after vaccination) and WALKING DISABILITY (started walking kind of funny after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not reported. Treatment information as not reported.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: a little soreness at the injection site which migrated to his back and upper shoulder and to the; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (a little soreness at the injection site which migrated to his back and upper shoulder and to the) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included POTASSIUM, FAMOTIDINE, LOSARTAN, DOXAZOSIN, HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE/HYDROCHLOROTHIAZIDE) and CLONIDINE for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN (a little soreness at the injection site which migrated to his back and upper shoulder and to the). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (a little soreness at the injection site which migrated to his back and upper shoulder and to the) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation delayed
Clinical narrative: I am not sure if after the first shot or second shot but my period was delayed for 4 months. When I did get it, was pretty heavy and lasted longer. The next period was delayed by 1.5 months and again heavy. My cramps started all over again which I haven?t experienced in last 20 years
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular, Polymenorrhoea
Clinical narrative: I have noticed since I have had the covid vaccine my period symptoms are different. Now it lasts from 6 to 7 days, previously it was a maximum of 5 days. The blood flow is much heavier since the shot. My period was on time at the beginning of the month for over a year, and since the vaccine it changed. My period will start at any time. Also in the past 3 weeks I have had my period in the beginning and now I am bleeding again. The workflow is enough to change tampons twice in the day. This bleeding is going on the third day.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Dizziness
Clinical narrative: Systemic: Abdominal Pain-Mild, Systemic: Dizziness / Lightheadness-Mild
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Lip swelling, Mouth swelling, Swelling face, Swollen tongue
Clinical narrative: Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: Patient reported swelling of lips and eyes several hours after injection. She did not require medical attention or experience difficulty breathing.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Injection site swelling, Insomnia, Pain
Clinical narrative: Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: she called that she had an ankle pain and swelling now in calf not recovering-Severe, Systemic: Joint Pain-Severe, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Unable to Sleep-Medium, Systemic: Weakness-Severe
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Peripheral swelling
Clinical narrative: Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: she called that she had an ankle pain and swelling now in calf not recovering-Severe, Systemic: Joint Pain-Severe, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Unable to Sleep-Medium, Systemic: Weakness-Severe
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Haematemesis
Clinical narrative: One episode of hematemesis several hours later
Sex: F
Vaccine: COVID19
Symptoms: Injection site discomfort, Injection site erythema, Injection site pain, Injection site pruritus, Rash
Clinical narrative: HIVES on her belly; Arm is extremely itchy; Arm is red; big patch above site of injection which goes of in 2 to 3 days; Arm is painful; Arm is hard to touch; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (HIVES on her belly), INJECTION SITE PRURITUS (Arm is extremely itchy), INJECTION SITE ERYTHEMA (Arm is red), RASH (big patch above site of injection which goes of in 2 to 3 days) and INJECTION SITE PAIN (Arm is painful) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced URTICARIA (HIVES on her belly), INJECTION SITE PRURITUS (Arm is extremely itchy), INJECTION SITE ERYTHEMA (Arm is red), RASH (big patch above site of injection which goes of in 2 to 3 days), INJECTION SITE PAIN (Arm is painful) and INJECTION SITE DISCOMFORT (Arm is hard to touch). At the time of the report, URTICARIA (HIVES on her belly), INJECTION SITE PRURITUS (Arm is extremely itchy), INJECTION SITE ERYTHEMA (Arm is red), RASH (big patch above site of injection which goes of in 2 to 3 days), INJECTION SITE PAIN (Arm is painful) and INJECTION SITE DISCOMFORT (Arm is hard to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: HIVES on her belly; Arm is extremely itchy; Arm is red; big patch above site of injection which goes of in 2 to 3 days; Arm is painful; Arm is hard to touch; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (HIVES on her belly), INJECTION SITE PRURITUS (Arm is extremely itchy), INJECTION SITE ERYTHEMA (Arm is red), RASH (big patch above site of injection which goes of in 2 to 3 days) and INJECTION SITE PAIN (Arm is painful) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced URTICARIA (HIVES on her belly), INJECTION SITE PRURITUS (Arm is extremely itchy), INJECTION SITE ERYTHEMA (Arm is red), RASH (big patch above site of injection which goes of in 2 to 3 days), INJECTION SITE PAIN (Arm is painful) and INJECTION SITE DISCOMFORT (Arm is hard to touch). At the time of the report, URTICARIA (HIVES on her belly), INJECTION SITE PRURITUS (Arm is extremely itchy), INJECTION SITE ERYTHEMA (Arm is red), RASH (big patch above site of injection which goes of in 2 to 3 days), INJECTION SITE PAIN (Arm is painful) and INJECTION SITE DISCOMFORT (Arm is hard to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: A reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (A reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (A reaction). At the time of the report, ADVERSE REACTION (A reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided   Most recent FOLLOW-UP information incorporated above includes: On 01-Feb-2021: NNI- TCR form
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Oral herpes, Pruritus
Clinical narrative: She felt like he was developing cold sores in her body; She is very itchy; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (She felt like he was developing cold sores in her body), PRURITUS (She is very itchy) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced CHILLS (Chills). On 31-Jan-2021, the patient experienced ORAL HERPES (She felt like he was developing cold sores in her body) and PRURITUS (She is very itchy). On 28-Jan-2021, CHILLS (Chills) had resolved. At the time of the report, ORAL HERPES (She felt like he was developing cold sores in her body) and PRURITUS (She is very itchy) outcome was unknown.            Concomitant and Treatment medications were not provided.   Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pruritus
Clinical narrative: Swelling of lymph nodes; Itching at the injection site; This spontaneous case was reported by a health care professional and describes the occurrence of LYMPHADENOPATHY (Swelling of lymph nodes) and VACCINATION SITE PRURITUS (Itching at the injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced LYMPHADENOPATHY (Swelling of lymph nodes) and VACCINATION SITE PRURITUS (Itching at the injection site). At the time of the report, LYMPHADENOPATHY (Swelling of lymph nodes) and VACCINATION SITE PRURITUS (Itching at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Vomiting
Clinical narrative: chills; nausea; vomiting; severe tiredness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and FATIGUE (severe tiredness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041620A) for COVID-19 vaccination.     The patient's past medical history included Suspected COVID-19 in March 2020. Family history included Immunocompromised (Family history of immunocompromised) since an unknown date.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and FATIGUE (severe tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and FATIGUE (severe tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Hot flush, Injection site rash
Clinical narrative: injection site rash; redness; hot; Fatigue; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FATIGUE (Fatigue), INJECTION SITE RASH (injection site rash), ERYTHEMA (redness) and HOT FLUSH (hot) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced FATIGUE (Fatigue). On 20-Jan-2021, the patient experienced INJECTION SITE RASH (injection site rash), ERYTHEMA (redness) and HOT FLUSH (hot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL N) for Rash, at an unspecified dose and frequency. On 19-Jan-2021, FATIGUE (Fatigue) had resolved. On 27-Jan-2021, ERYTHEMA (redness) and HOT FLUSH (hot) had resolved. On 29-Jan-2021, INJECTION SITE RASH (injection site rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Condition aggravated, Dyspnoea
Clinical narrative: chest pain; shortness of breath; worsening symptoms; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (chest pain), DYSPNOEA (shortness of breath) and ADVERSE REACTION (worsening symptoms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Shortness of breath.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pain), DYSPNOEA (shortness of breath) and ADVERSE REACTION (worsening symptoms). At the time of the report, CHEST PAIN (chest pain), DYSPNOEA (shortness of breath) and ADVERSE REACTION (worsening symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not reported. No concomitant medications reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pruritus, Urticaria
Clinical narrative: MALAISE; itchy; itchiness which felt like hives without raised, physical hives; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (MALAISE), PRURITUS (itchy) and URTICARIA (itchiness which felt like hives without raised, physical hives) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included THYROID (ARMOUR THYROID), PENTOSAN POLYSULFATE SODIUM (ELMIRON), THIAMINE HYDROCHLORIDE (THIAMIN HCL), METFORMIN, estrogen replacement, Fritilizem, Water pills, ESOMEPRAZOLE, ATORVASTATIN CALCIUM (LIPITOR), LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL), DEXAMETHASONE, DIPROPHYLLINE, TETRACYCLINE HYDROCHLORIDE, TRYPSIN (PULMOCORTISON INY), MONTELUKAST SODIUM (SINGULAIR), SALMETEROL XINAFOATE (SEREVENT) and SALBUTAMOL (ALBUTEROL HFA) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced MALAISE (MALAISE), PRURITUS (itchy) and URTICARIA (itchiness which felt like hives without raised, physical hives). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Hives, at an unspecified dose and frequency. On 03-Feb-2021, MALAISE (MALAISE), PRURITUS (itchy) and URTICARIA (itchiness which felt like hives without raised, physical hives) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore at injection site). At the time of the report, VACCINATION SITE PAIN (Sore at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: heart rising, and felted more when eating; A spontaneous report was received from a Consumer concerning a 40-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events heart rising, and felted more when eating.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 12 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 012220A) intramuscularly in her left arm for prophylaxis of COVID-19 infection.  On 13 Jan 2021, the patient experienced the events heart rising and felted more when eating.   No treatment details were included.  Action taken with mRNA-1273 in response to the events was not reported.   On 3 Feb 2021 the outcome of events heart rising was resolved. On unknown date the outcome of events felted more when eating was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. The described "heart rising" is likely a description of increased heart rate.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Dyspnoea, Nausea
Clinical narrative: light headed and feel like faint; chest feels heavy; fainty breathless; nauseated; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light headed and feel like faint), CHEST DISCOMFORT (chest feels heavy), DYSPNOEA (fainty breathless) and NAUSEA (nauseated) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included COLESTIPOL, PENCICLOVIR, AMBROXOL, SERTRALINE, OXYCODONE, TOPIRAMATE, ONDANSETRON and GABAPENTIN for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced DIZZINESS (light headed and feel like faint), CHEST DISCOMFORT (chest feels heavy), DYSPNOEA (fainty breathless) and NAUSEA (nauseated). At the time of the report, DIZZINESS (light headed and feel like faint), CHEST DISCOMFORT (chest feels heavy), DYSPNOEA (fainty breathless) and NAUSEA (nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included, an anti nausea pill was provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: backache in kidney went away after receiving vaccine; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (She had backache in her kidneys for 2 weeks and today 02Feb2021 she received the vaccine) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included Back ache (had backache in her kidneys for 2 weeks.).    On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (She had backache in her kidneys for 2 weeks and today 02Feb2021 she received the vaccine). On 03-Feb-2021, BACK PAIN (She had backache in her kidneys for 2 weeks and today 02Feb2021 she received the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Thyroid medication and, water pills to make urinate.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: knee pain has gotten worse in the last few days; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (knee pain has gotten worse in the last few days) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) injection for COVID-19 vaccination.     The patient's past medical history included Knee pain. Concomitant products included PARACETAMOL (TYLENOL), GABAPENTIN, METOPROLOL, HYDROCHLOROTHIAZIDE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12) and ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) for an unknown indication.    On an unknown date, the patient started mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ARTHRALGIA (knee pain has gotten worse in the last few days). At the time of the report, ARTHRALGIA (knee pain has gotten worse in the last few days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity
Clinical narrative: at night she felt extremely hot,; saw her face in the mirror, it was not even red, it was on fire, like the worst sunburn ever; little sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little sore left arm), FEELING HOT (at night she felt extremely hot,) and ERYTHEMA (saw her face in the mirror, it was not even red, it was on fire, like the worst sunburn ever) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL + HIDROCLOROTIAZIDA) and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (little sore left arm). On 02-Feb-2021, the patient experienced FEELING HOT (at night she felt extremely hot,) and ERYTHEMA (saw her face in the mirror, it was not even red, it was on fire, like the worst sunburn ever). At the time of the report, PAIN IN EXTREMITY (little sore left arm), FEELING HOT (at night she felt extremely hot,) and ERYTHEMA (saw her face in the mirror, it was not even red, it was on fire, like the worst sunburn ever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Nervousness, Palpitations, Paraesthesia, Product dose omission issue
Clinical narrative: She felt nervous all over; Has not received the second dose (>36 days after first dose); Still having tingling in her legs; Heart Pounding; Leg Cramps; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Leg Cramps), NERVOUSNESS (She felt nervous all over), PARAESTHESIA (Still having tingling in her legs) and PRODUCT DOSE OMISSION ISSUE (Has not received the second dose (>36 days after first dose)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included Walking pneumonia (Patient had walking pneumonia 3 years ago. Patient was given a quinolone (antibiotic). It has affected nervous system in legs and back and got better after a year.) in 2017.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced MUSCLE SPASMS (Leg Cramps) and PARAESTHESIA (Still having tingling in her legs). On an unknown date, the patient experienced NERVOUSNESS (She felt nervous all over) and PRODUCT DOSE OMISSION ISSUE (Has not received the second dose (>36 days after first dose)). At the time of the report, MUSCLE SPASMS (Leg Cramps), NERVOUSNESS (She felt nervous all over) and PRODUCT DOSE OMISSION ISSUE (Has not received the second dose (>36 days after first dose)) outcome was unknown and PARAESTHESIA (Still having tingling in her legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow-up document was received. Additional events were  added. It contains significant information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain
Clinical narrative: I felt soreness in the shoulder blade and lower neck area on the left side that I got the shot; I felt soreness in the shoulder blade and lower neck area on the left side that I got the shot; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (I felt soreness in the shoulder blade and lower neck area on the left side that I got the shot) and ARTHRALGIA (I felt soreness in the shoulder blade and lower neck area on the left side that I got the shot) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (I felt soreness in the shoulder blade and lower neck area on the left side that I got the shot) and ARTHRALGIA (I felt soreness in the shoulder blade and lower neck area on the left side that I got the shot). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form, bid. At the time of the report, NECK PAIN (I felt soreness in the shoulder blade and lower neck area on the left side that I got the shot) and ARTHRALGIA (I felt soreness in the shoulder blade and lower neck area on the left side that I got the shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow-up was received on 29-JUN-2021 contains significant information. outcome of the events were updated
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: hot to touch; itching in injection arm; swelling in injection arm; redness in injection arm; mild soreness in her injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (itching in injection arm), VACCINATION SITE PAIN (mild soreness in her injection arm), VACCINATION SITE SWELLING (swelling in injection arm) and VACCINATION SITE ERYTHEMA (redness in injection arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included Sensitive skin (had to use hypoallergenic products on her skin).    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (mild soreness in her injection arm). On 30-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (itching in injection arm), VACCINATION SITE SWELLING (swelling in injection arm) and VACCINATION SITE ERYTHEMA (redness in injection arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; HYDROCORTISONE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE (EQUATE ANTI ITCH) at a dose of continuous spray. On 21-Jan-2021, VACCINATION SITE PAIN (mild soreness in her injection arm) had resolved. At the time of the report, VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (itching in injection arm), VACCINATION SITE SWELLING (swelling in injection arm) and VACCINATION SITE ERYTHEMA (redness in injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: diagnosed with shingles several days after receiving the first dose of the Moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (diagnosed with shingles several days after receiving the first dose of the Moderna vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (diagnosed with shingles several days after receiving the first dose of the Moderna vaccine). At the time of the report, HERPES ZOSTER (diagnosed with shingles several days after receiving the first dose of the Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Nausea, Pain, Pyrexia
Clinical narrative: Soreness in left arm; Headache; Nausea; Fever of 100.5 degrees; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness in left arm), HEADACHE (Headache), NAUSEA (Nausea) and PYREXIA (Fever of 100.5 degrees) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN (Soreness in left arm), HEADACHE (Headache), NAUSEA (Nausea) and PYREXIA (Fever of 100.5 degrees). At the time of the report, PAIN (Soreness in left arm), HEADACHE (Headache), NAUSEA (Nausea) and PYREXIA (Fever of 100.5 degrees) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2021, Body temperature: 100.5 (High) 100.5 degree.         No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Myalgia, Nausea
Clinical narrative: Nausea; Body ache; low energy; Discomfort in the stomach; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), MYALGIA (Body ache), ABDOMINAL DISCOMFORT (Discomfort in the stomach) and ASTHENIA (low energy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-1903, the patient experienced ABDOMINAL DISCOMFORT (Discomfort in the stomach). On 25-Jan-2021, the patient experienced NAUSEA (Nausea), MYALGIA (Body ache) and ASTHENIA (low energy). At the time of the report, NAUSEA (Nausea), MYALGIA (Body ache), ABDOMINAL DISCOMFORT (Discomfort in the stomach) and ASTHENIA (low energy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Several days with side effects; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Injection site pruritus, Seizure, Tremor
Clinical narrative: Site: Itching at Injection Site-Mild, Systemic: Chills-Mild, Systemic: Seizure-Medium, Systemic: Shakiness-Mild
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chills, Dizziness, Flushing, Hyperhidrosis
Clinical narrative: Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Severe, Systemic: Shakiness-Medium, Systemic: Vomiting-Severe, Additional Details: Patient was very anxious about this particular vaccine and hated needles - 5 minutes after she was pale, sweating, and throwing up. She waited here for 30 minutes and then said she felt back to normal and left.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pallor, Tremor, Vomiting
Clinical narrative: Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Severe, Systemic: Shakiness-Medium, Systemic: Vomiting-Severe, Additional Details: Patient was very anxious about this particular vaccine and hated needles - 5 minutes after she was pale, sweating, and throwing up. She waited here for 30 minutes and then said she felt back to normal and left.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: Systemic: Seizure-Mild, Additional Details: patient was on flight with mom and developed a seizure 9 days after receiving seizure. Patient had no prior history of seizures. Seziure lasted no more than 5 minutes. luckily a few doctors and nurses were on flight and they handeled the situation.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Clonic convulsion, Dizziness, Seizure, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Seizure-Mild, Additional Details: pt went undresponsive, hx of this, 20 seconds of clonic seisure was responsive to sternal rub.  After 10 min progressed from laying to sitting in chair and sipping water got RN that was on site. PT started feeling worse and went unresponsive again no seisures this time EMS (america medical was called), PT left our facility AMA.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Hyperhidrosis
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Nausea, Pain in extremity, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Systemic: Weakness-Mild, Additional Details: After the patient received the 2nd dose patient complained of arm pain and then became unresponsive. Mother and I supported her head and asked if she was okay. Mother described that this had happened in the past when she was younger with vaccinations. She became responsive after about 1 minute. Patient became nauseated and vomited. We got her some water and some goldfish crackers because she had not eaten that morning. Patient and Mother stayed in the vaccine room for 30 minutes.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Systemic: Weakness-Mild, Additional Details: After the patient received the 2nd dose patient complained of arm pain and then became unresponsive. Mother and I supported her head and asked if she was okay. Mother described that this had happened in the past when she was younger with vaccinations. She became responsive after about 1 minute. Patient became nauseated and vomited. We got her some water and some goldfish crackers because she had not eaten that morning. Patient and Mother stayed in the vaccine room for 30 minutes.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Hyperhidrosis, Syncope
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium